Department Biologie

J109: EV profiling: a potential window into the pathogenesis of Parkinson’s disease Jan. 1, 2024 - June 30, 2026 J105: Glucose transporter type 1: Metabolic controller of plasma cell longevity and antibody function? Oct. 1, 2023 - March 31, 2026 Erweiterung des Repertoires chimärer Antigenrezeptoren (CARs) zur Tumorabwehr: Neue Effektoren und neue Aktivierungswege Oct. 1, 2022 - Oct. 1, 2025 A101: Atypical, anti-viral IgG4 antibody responses after SARS-CoV-2 mRNA vaccination April 1, 2023 - Sept. 30, 2025 P04: Regulation of immune complex-mediated DC-dependent immune responses by DCIR (GRK 2599 FAIR P04) GRK 2599: FAIR - Fine-Tuners of the Adaptive Immune Response Jan. 1, 2021 - July 30, 2025 A096: Molecular and functional analysis of immune/ intestinal epithelial cell-interaction during CMV infection Jan. 1, 2023 - June 30, 2025 Einfluss zellulärer und humoraler Immunkomponenten in den initialen Phasen der RA (TP 06) PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis Jan. 1, 2022 - Dec. 31, 2024 Mapping the effector response space of antibody combination Dec. 18, 2019 - Nov. 30, 2024 Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. (HYPERBOOST) HYPERBOOST: Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. Dec. 1, 2020 - Nov. 30, 2024 Consortium for Immunotherapeutics against Emerging Viral Threats May 1, 2019 - April 30, 2024